Literature DB >> 24569980

Myricetin blocks lipoteichoic acid-induced COX-2 expression in human gingival fibroblasts.

Gloria Gutiérrez-Venegas1, Oscar Alonso Luna, Juan Antonio Arreguín-Cano, Cristina Hernández-Bermúdez.   

Abstract

Periodontitis is an infectious disease caused by microorganisms present in dental bacterial plaque. Lipoteichoic acid (LTA) is a component of the external membrane of Gram-positive bacteria. It causes septic shock. Ingested flavonoids have been reported to directly affect the regulation of cyclooxygenase-2 (COX-2) expression induced by bacterial toxins. In this study, we examined the effects of four flavonoids (luteolin, fisetin, morin and myricetin) on the activation of ERK1/2, p38 and AKT, and on the synthesis of COX-2 in human gingival fibroblasts treated with LTA from Streptococcus sanguinis. We found that luteolin and myricetin blocked AKT and p38 activation and that myricetin blocked LTA-induced COX-2 expression. The results of our study are important for elucidating the mechanism of action of flavonoid regulation of inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24569980      PMCID: PMC6276007          DOI: 10.2478/s11658-014-0186-4

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  4 in total

Review 1.  Myricetin: A Dietary Molecule with Diverse Biological Activities.

Authors:  Deepak Kumar Semwal; Ruchi Badoni Semwal; Sandra Combrinck; Alvaro Viljoen
Journal:  Nutrients       Date:  2016-02-16       Impact factor: 5.717

2.  Lipoteichoic acid reduces antioxidant enzymes in H9c2 cells.

Authors:  Berenice Fernández-Rojas; Gustavo I Vázquez-Cervantes; José Pedraza-Chaverri; Gloria Gutiérrez-Venegas
Journal:  Toxicol Rep       Date:  2019-12-30

3.  Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer.

Authors:  Raju Dash; Mir Muhammad Nasir Uddin; S M Zahid Hosen; Zahed Bin Rahim; Abu Mansur Dinar; Mohammad Shah Hafez Kabir; Ramiz Ahmed Sultan; Ashekul Islam; Md Kamrul Hossain
Journal:  Bioinformation       Date:  2015-12-31

4.  Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway.

Authors:  Hai-Han Liao; Nan Zhang; Yan-Yan Meng; Hong Feng; Jing-Jing Yang; Wen-Jin Li; Si Chen; Hai-Ming Wu; Wei Deng; Qi-Zhu Tang
Journal:  Oxid Med Cell Longev       Date:  2019-12-06       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.